<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37255755</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients.</ArticleTitle><Pagination><StartPage>1155951</StartPage><MedlinePgn>1155951</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1155951</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1155951</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Post-COVID-19 syndrome (PCS) usually occurs 3 months after the onset of COVID-19 with a symptom duration of at least 2 months without an alternative diagnosis.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to describe the prevalence, characteristics, and impact on the quality of life (QoL) of post-COVID-19 syndrome in patients with a history of hospitalization for COVID-19.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We conducted a cross-sectional study. Patients who required hospitalization due to COVID-19 between March 2020 and October 2021 were invited to answer a PCS questionnaire and the EQ-5D instrument. A total of 246 patients were included: 187 (76%) met the definition of PCS and 54% were men, with a median age of 50 years (IQR 41-63).</AbstractText><AbstractText Label="RESULTS">From 187 patients with PCS, the median time to symptom onset after hospital discharge was 1 day (IQR 1-20), and the median symptom duration was 150 days (IQR 90-225). A total of 27 different symptoms were reported; the most frequent were difficulty concentrating (81%), dyspnea (75%), arthralgia (71%), fatigue (68%), and hair loss (60%). Some symptoms, such as difficulty concentrating, arthralgia/myalgia, and hair loss, were more prevalent in women with PCS. Patients with PCS had a higher frequency of tobacco smoking (37 vs. 4%, <i>p</i> = 0.02) and increased severity of lung involvement in the initial chest tomography (75 vs. 58%, <i>p</i> = 0.01) than those without PCS. Patients with PCS were less likely to receive antivirals (15.5 vs. 27%, <i>p</i> = 0.04). No difference between ICU admission, mechanical ventilation, and length of hospital stay was found. Patients with PCS had a lower visual analog scale result for EQ-5D vs. those without (80 [IQR 70-90] vs. 89.5 [IQR 75-90], <i>p</i> = 0.05). All five QoL dimensions were affected in PCS patients, showing increased pain/discomfort (67 vs. 39%, <i>p</i> = &lt; 0.001), difficulties in performing usual activities (39.2 vs. 20.3%, <i>p</i> = 0.03), and anxiety/depression (57.5 vs. 37%, <i>p</i> = 0.02).</AbstractText><AbstractText Label="CONCLUSION">PCS occurred in 76% of hospitalized patients with prolonged duration and QoL impairment. Neurological symptoms such as difficulty concentrating were the most frequent symptoms. Timely diagnostic and therapeutic interventions are required.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Rom&#xe1;n-Montes, Flores-Soto, Guaracha-Basa&#xf1;ez, Tamez-Torres, Sifuentes-Osornio, Gonz&#xe1;lez-Lara and Le&#xf3;n.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rom&#xe1;n-Montes</LastName><ForeName>Carla Marina</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Clinical Microbiology Laboratory, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Department, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores-Soto</LastName><ForeName>Yesenia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Microbiology Laboratory, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guaracha-Basa&#xf1;ez</LastName><ForeName>Guillermo Arturo</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Emergency Department, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamez-Torres</LastName><ForeName>Karla Mar&#xed;a</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Clinical Microbiology Laboratory, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sifuentes-Osornio</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General Direction, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Lara</LastName><ForeName>Ma Fernanda</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Clinical Microbiology Laboratory, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Le&#xf3;n</LastName><ForeName>Alfredo Ponce</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mexican</Keyword><Keyword MajorTopicYN="N">chronic COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">severe COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>10</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37255755</ArticleId><ArticleId IdType="pmc">PMC10225709</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1155951</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>El-Sadr WM, Vasan A, El-Mohandes A. Facing the New Covid-19 Reality. N Engl J Med. (2023) 388:385&#x2013;7. 10.1056/NEJMp2213920</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2213920</ArticleId><ArticleId IdType="pubmed">36724378</ArticleId></ArticleIdList></Reference><Reference><Citation>Organisation WH . A clinical case definition of post COVID-19 condition by a Delphi consensus data. (2021). Available online at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (accessed December 23, 2021).</Citation></Reference><Reference><Citation>Leon SL, Ostrosky TW, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More than 50 long - term effects of COVID - 19 : a systematic review and meta - analysis Middle East respiratory syndrome. Nat Sci Reports. (2021) 11:1&#x2013;12. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Among SO, Hospitalized P. Sixty-day outcomes among patients hospitalized with. Ann Intern Med Med. (2022) 174:2021&#x2013;3. 10.7326/M20-5661</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q, Sheikh A, Daines L, Vasileiou E. Symptoms and signs of long COVID: A rapid review and meta-analysis. J Glob Health. (2022) 12:5014. 10.7189/jogh.12.05014</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>The WHOQOL Group . WHO Quality of Life Scale (WHOQOL). Psychol Med. (1998) 28:551&#x2013;8. 10.1017/S0033291798006667</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291798006667</ArticleId><ArticleId IdType="pubmed">9626712</ArticleId></ArticleIdList></Reference><Reference><Citation>Pequeno N, Cabral N, Marchioni D, Lima S, Lyra C. Quality of life assessment instruments for adults: a systematic review of population-based studies. Health Qual Life Outcomes. (2020) 18:1&#x2013;13. 10.1186/s12955-020-01347-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01347-7</ArticleId><ArticleId IdType="pmc">PMC7329518</ArticleId><ArticleId IdType="pubmed">32605649</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollmann M, Garin O, Galante M, Ferrer M, Dominguez A, Alonso J. Impact of Influenza on Health-Related Quality of Life among Confirmed (H1N1)2009 Patients. PLoS ONE. (2013) 8:1&#x2013;10. 10.1371/journal.pone.0060477</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0060477</ArticleId><ArticleId IdType="pmc">PMC3610925</ArticleId><ArticleId IdType="pubmed">23555979</ArticleId></ArticleIdList></Reference><Reference><Citation>Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI, et al. . Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review. Qual Life Res. (2021) 30:3367&#x2013;81. 10.1007/s11136-021-02908-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02908-z</ArticleId><ArticleId IdType="pmc">PMC8214069</ArticleId><ArticleId IdType="pubmed">34146226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapin B, Katzan IL. Health-related quality of life mildly affected following COVID-19: a retrospective pre-post cohort study with a propensity score&#x2013;matched control group. J Gen Intern Med. (2022) 37:862&#x2013;9. 10.1007/s11606-021-07340-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07340-0</ArticleId><ArticleId IdType="pmc">PMC8757401</ArticleId><ArticleId IdType="pubmed">35025068</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel AN, Zhu S, Cooper N, Roderick P, Alwan N, Tarrant C, et al. . Impact of Covid-19 on health-related quality of life of patients: A structured review. PLoS ONE. (2021) 16:1&#x2013;20. 10.1371/journal.pone.0259164</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259164</ArticleId><ArticleId IdType="pmc">PMC8553121</ArticleId><ArticleId IdType="pubmed">34710173</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Delgado C, Galindo-Su&#xe1;rez RM, Cruz-Santiago C, Shah K, Papadimitropoulos M, Feng Y, et al. . EQ-5D-5L Health-State Values for the Mexican Populaton.pdf. Appl Health Econ Health Policy. (2021) 19:905&#x2013;14. 10.1007/s40258-021-00658-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40258-021-00658-0</ArticleId><ArticleId IdType="pmc">PMC8545780</ArticleId><ArticleId IdType="pubmed">34173957</ArticleId></ArticleIdList></Reference><Reference><Citation>Group TE. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy (New York). (1990) 16:199&#x2013;208. 10.1016/0168-8510(90)90421-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8510(90)90421-9</ArticleId><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. . Radiological society of North America expert consensus document on reporting chest CT findings related to COVID-19: Endorsed by the society of thoracic radiology, the American college of radiology, and RSNA. Radiol Cardiothorac Imaging. (2020) 2:e200152. 10.1148/ryct.2020200152</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryct.2020200152</ArticleId><ArticleId IdType="pmc">PMC7233447</ArticleId><ArticleId IdType="pubmed">33778571</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Green J, Druckman J, Lazer D, et al. . Factors associated with self-reported symptoms of depression among adults with and without a previous COVID-19 diagnosis. JAMA Netw Open. (2021) 4:9&#x2013;12. 10.1001/jamanetworkopen.2021.16612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.16612</ArticleId><ArticleId IdType="pmc">PMC8196339</ArticleId><ArticleId IdType="pubmed">34115130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz-Corona C, Guti&#xe9;rrez-Canales LG, Ortiz-Ledesma C, Mart&#xed;nez-Navarro LJ, Mac&#xed;as AE, Scavo-Montes DA, et al. . Quality of life and persistence of COVID-19 symptoms 90 days after hospital discharge. J Int Med Res. (2022) 50:03000605221110492. 10.1177/03000605221110492</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605221110492</ArticleId><ArticleId IdType="pmc">PMC9284218</ArticleId><ArticleId IdType="pubmed">35822272</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Tejada CE, Herrera-Garc&#xed;a CF, Godina-Gonz&#xe1;lez S, Villagrana-Ba&#xf1;uelos KE, Amaro JDDL, Herrera-Garc&#xed;a K, et al. . Persistence of covid-19 symptoms after recovery in mexican population. Int J Environ Res Public Health. (2020) 17:1&#x2013;12. 10.3390/ijerph17249367</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17249367</ArticleId><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe KEB, et al. . Long COVID occurrence in COVID-19 survivors. Sci Rep. (2022) 12:1&#x2013;11. 10.1038/s41598-022-10051-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10051-z</ArticleId><ArticleId IdType="pmc">PMC8996498</ArticleId><ArticleId IdType="pubmed">35411017</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. . Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J Clin Med. (2022) 11:1&#x2013;10. 10.3390/jcm11020413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid - Mechanisms, risk factors, and management. BMJ. (2021) 374:1&#x2013;18. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. (2021) 24:168&#x2013;75. 10.1101/2020.06.04.135012</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.04.135012</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto OH. Cognitive sequelae of COVID-19, a post-pandemic threat: Should we be worried about the brain fog? Arq Neuropsiquiatr. (2022) 80:215&#x2013;6. 10.1590/0004-282x-anp-2022-e003</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282x-anp-2022-e003</ArticleId><ArticleId IdType="pmc">PMC9648928</ArticleId><ArticleId IdType="pubmed">35416840</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Silva FD, Garc&#xed;a-Grimshaw M, Vald&#xe9;s-Ferrer SI, Vigueras-Hern&#xe1;ndez AP, Dom&#xed;nguez-Moreno R, Trist&#xe1;n-Samaniego DP, et al. . Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City. PLoS ONE. (2021) 16:1&#x2013;12. 10.1371/journal.pone.0247433</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247433</ArticleId><ArticleId IdType="pmc">PMC8031187</ArticleId><ArticleId IdType="pubmed">33831042</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Chew RM, Rodr&#xed;guez Cabrera EX, Rodr&#xed;guez Valdez CA, Lomelin-Gascon J, Morales-Ju&#xe1;rez L, de la Cerda ML, et al. . Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City. Ther Adv Infect Dis. (2022) 9:1&#x2013;17. 10.1177/20499361211069264</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211069264</ArticleId><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="pubmed">35059196</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:1&#x2013;24. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohyama M, Matsudo K, Fujita T. Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management. J Dermatol. (2022) 49:939&#x2013;47. 10.1111/1346-8138.16475</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.16475</ArticleId><ArticleId IdType="pmc">PMC9348110</ArticleId><ArticleId IdType="pubmed">35633047</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. . Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. (2021) 27:89&#x2013;95. 10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyfi S, Alijanpour R, Aryanian Z, Ezoji K, Mahmoudi M. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity. J Med Life. (2022) 15:631&#x2013;4. 10.25122/jml-2021-0380</Citation><ArticleIdList><ArticleId IdType="doi">10.25122/jml-2021-0380</ArticleId><ArticleId IdType="pmc">PMC9262270</ArticleId><ArticleId IdType="pubmed">35815081</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth&#xe9;l&#xe9;my H, Mougenot E, Duracinsky M, Salmon-Ceron D, Bonini J, P&#xe9;retz F, et al. . Smoking increases the risk of post-acute COVID-19 syndrome: Results from a French community-based survey. Tob Induc Dis. (2022) 20:1&#x2013;10. 10.18332/tid/150295</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tid/150295</ArticleId><ArticleId IdType="pmc">PMC9204712</ArticleId><ArticleId IdType="pubmed">35799625</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. (2022) 13:1&#x2013;10. 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Emecen AN, Keskin S, Turunc O, Suner AF, Siyve N, Basoglu Sensoy E, et al. . The presence of symptoms within 6 months after COVID-19: a single-center longitudinal study. Ir J Med Sci. (2022) 192:741&#x2013;50. 10.1007/s11845-022-03072-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-022-03072-0</ArticleId><ArticleId IdType="pmc">PMC9205653</ArticleId><ArticleId IdType="pubmed">35715663</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. . Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. (2022) 53:1&#x2013;19. 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. (2021) 75:1&#x2013;5. 10.1111/ijcp.13746</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, Martino M De, Gerussi V, Graziano E, et al. . Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. (2021) 27:1507&#x2013;13. 10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. . Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. (2021) 20:1&#x2013;18. 10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L, Meli G, Poletti F, Rostagno R, Moglia R, Cantone M, et al. . Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM. (2022) 114:865&#x2013;71. 10.1093/qjmed/hcab297</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab297</ArticleId><ArticleId IdType="pmc">PMC8690187</ArticleId><ArticleId IdType="pubmed">34850210</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Moreno E, Pita-romero R, Leal S, Sanduende Y, Rodri A, et al. . Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. (2020) 126:e110&#x2013;3. 10.1016/j.bja.2020.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Paleoudis EG, Bari DL Di, Nyirenda T, Friedman T, Gupta A, et al. . Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. (2020) 15:1&#x2013;14. 10.1371/journal.pone.0243882</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandasena HMRKG, Pathirathna ML, Atapattu AMMP, Prasanga PTS. Quality of life of COVID 19 patients after discharge: Systematic review. PLoS ONE. (2022) 17:1&#x2013;12. 10.1371/journal.pone.0263941</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263941</ArticleId><ArticleId IdType="pmc">PMC8849513</ArticleId><ArticleId IdType="pubmed">35171956</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiolliere F, Falandry C, Allaouchiche B, Geoffray V, Bitker L, Reignier J, et al. . Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse? Crit Care. (2022) 26:1&#x2013;8. 10.1186/s13054-022-03958-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-03958-6</ArticleId><ArticleId IdType="pmc">PMC8978758</ArticleId><ArticleId IdType="pubmed">35379312</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance H, Maslach A, Stoneman E, Harmes K, Ransom A, Seagly K, et al. . Addressing post-COVID symptoms: A guide for primary care physicians. J Am Board Fam Med. (2021) 36:1229&#x2013;42. 10.3122/jabfm.2021.06.210254</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.2021.06.210254</ArticleId><ArticleId IdType="pubmed">34772779</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of Long COVID-19 caused by different SARS-CoV-2 strains: a systematic review and meta-analysis. Int J Environ Res Public Health. (2022) 19:1&#x2013;15. 10.3390/ijerph192316010</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>